Amerikanische Gesellschaft für Hirudotherapie

A four-year community hospital experience regarding procedures for the replantation and revascularization of fingers

Retrospective study published in Jt Dis Relat Surg (2021)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportKlinische StudienGurbuz K et al. · Joint diseases and related surgery, 2021

Abstract

OBJECTIVES: This study aims to evaluate the clinical results and experiences in a community hospital regarding procedures for the replantation and revascularization of fingers. PATIENTS AND METHODS: Between June 2015 and December 2019, a total of 58 patients (51 males, 7 females; mean age: 33.4±6.3 years; range, 23 to 46 years) who were followed after total and/or subtotal amputation and replantation were retrospectively analyzed. The patients were evaluated at nine months in terms of cold intolerance, static two-point discrimination, and functional results using the range of motion (ROM) and Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) questionnaire. RESULTS: The majority of the patients presented with work-related injuries (70%), most commonly by the mechanism of guillotine (64%), and to the dominant hand (76%) and the third finger (36%) most frequently. The overall success rate of digit salvage was 72.9% (n=51). Of 19 digits with unsuccessful surgical outcomes, seven were from total and 12 were from subtotal amputations. In the long-term, cold intolerance was observed in 14 patients (24.1%) according to the cold intolerance severity scale. The mean static two-point discrimination value was 6.0±0.7 mm and the mean QuickDASH score was 22.3±5.0. The mean ROM measured at nine months after surgery in the metacarpophalangeal and interphalangeal joints of the third and fourth digits was significantly lower than that in the others (p<0.05). CONCLUSION: The predictors of survival of a replanted digit indicated in this study can be used as a guide and decision-making aid for any attempts for replantation.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAdultAmputation, TraumaticCold TemperatureFemaleFinger InjuriesFinger JointFingersHospitals, CommunityHumansMaleMetacarpophalangeal JointMiddle Aged

Zusammenfassung

Community-hospital retrospective study of 58 patients with 72.9% digit-salvage success rate after finger replantation/revascularization.

Warum dies für die Hirudotherapie relevant ist

This retrospective study analyzed 58 patients who underwent finger replantation or revascularization at a community hospital over four years, reporting a 72.9% overall digit salvage success rate and providing data on cold intolerance, two-point discrimination, and functional outcomes. The study makes no mention of leech therapy, hirudotherapy, or venous congestion management. There is no defensible leech-related relevance to ASH's domain in this article, which focuses entirely on surgical technique and outcomes predictors for digit replantation without addressing any adjunctive biological therapies.

Zitation

A four-year community hospital experience regarding procedures for the replantation and revascularization of fingers.

Gurbuz K et al. · Joint diseases and related surgery, 2021

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.